Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Medulloblastoma 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Choroid Plexus Neoplasms 1Carcinoma, Renal Cell 1Burkitt Lymphoma 1Blast Crisis 1Astrocytoma 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Carboplatin 10Temozolomide 9Filgrastim 7Vincristine 4Irinotecan 4Etoposide 4Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3O(6)-benzylguanine 3Granulocyte Colony-Stimulating Factor 3Vorinostat 2Psychiatric Rehabilitation 2Oxaliplatin 2Lenalidomide 2Cilengitide 2Busulfan 2veliparib 1trioctyl phosphine oxide 1tipifarnib 1romidepsin 1pomalidomide 1pazopanib 1lonafarnib 1laromustine 1ixabepilone 1ispinesib 1imetelstat 1exatecan 1emvododstat 1cediranib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Optic Nerve Glioma × CK0238273 × Clear all
NCT00363272 2013-01-16

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
CNSLymphoidSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Medulloblastoma, Spinal Cord Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡